Immediate Impact
3 from Science/Nature 50 standout
Citing Papers
Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
2022 Standout
Works of Edward C. Knoblock being referenced
Elevation of Plasma Epinephrine Levels Produced by Glucagonin Vivo
1963
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Edward C. Knoblock | 82 | 137 | 10 | 118 | 94 | 34 | 622 | |
| André Valle de Bairros | 102 | 125 | 6 | 100 | 46 | 28 | 650 | |
| Gabor Komaromy-Hiller | 173 | 90 | 8 | 63 | 40 | 17 | 530 | |
| Glen D. Lawrence | 128 | 34 | 7 | 52 | 60 | 32 | 675 | |
| N P Kubasik | 80 | 80 | 88 | 91 | 34 | 41 | 616 | |
| Wei‐Chang Tseng | 136 | 98 | 155 | 66 | 23 | 565 | ||
| Denise Bohrer | 87 | 42 | 2 | 220 | 61 | 26 | 626 | |
| D. Pradeau | 66 | 94 | 2 | 58 | 37 | 57 | 548 | |
| Takafumi Ohta | 138 | 36 | 29 | 57 | 22 | 60 | 732 | |
| A. M. Jiménez | 150 | 133 | 2 | 23 | 51 | 33 | 735 | |
| Anna Błażewicz | 97 | 55 | 7 | 220 | 22 | 44 | 698 |
All Works
Loading papers...